Fosaprepitant Dimeglumine

CAS 265121-04-8 17 current recordsSmall Molecule

Who holds supplier records for Fosaprepitant Dimeglumine? 17 organisations hold a current record for Fosaprepitant Dimeglumine: an active US FDA Type II Drug Master File. Recorded organisation countries for current records: India (9), China (4), United States (1), Taiwan (1) and 1 other country (1); not recorded for 1.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Fosaprepitant Dimeglumine: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/fosaprepitant-dimeglumine

Reading the evidence

  • 17 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 9 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

  • US product patents listed

    The latest patent listed in the FDA Orange Book for an approved product containing Fosaprepitant Dimeglumine expires 11 Jan 2039. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.

Current records (17)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Fosaprepitant Dimeglumine. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Fosaprepitant Dimeglumine sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

US product patents and exclusivity

The FDA Orange Book lists patents and exclusivities for specific approved products (13 listed products contain Fosaprepitant Dimeglumine). The latest listed patent expires 11 Jan 2039. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Fosaprepitant Dimeglumine is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1201782).

Chemical identity

IUPAC name
5-[[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholin-4-yl]methyl]-2-phosphonato-1H-1,2,4-triazol-3-one;bis(methyl-[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]azanium)
Canonical SMILES
C[C@H](C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)O[C@@H]2[C@@H](N(CCO2)CC3=NC(=O)N(N3)P(=O)([O-])[O-])C4=CC=C(C=C4)F.C[NH2+]C[C@@H]([C@H]([C@@H]([C@@H](CO)O)O)O)O.C[NH2+]C[C@@H]([C@H]([C@@H]([C@@H](CO)O)O)O)O
InChIKey
VRQHBYGYXDWZDL-OOZCZQCLSA-N
Synonyms
Emend, Focinvez, Fosaprepitant (as dimeglumine), Fosaprepitant dimeglumine, Fosaprepitant meglumine, Ivemend, MK-0517

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Substance P/Neurokinin-1 Receptor Antagonist
Mechanism of action
Cytochrome P450 2C9 Inducers; Cytochrome P450 3A4 Inducers; Cytochrome P450 3A4 Inhibitors; Neurokinin 1 Antagonists

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Fosaprepitant Dimeglumine?

17 organisations hold an active US FDA Type II Drug Master File or a CEP for Fosaprepitant Dimeglumine: ALIVUS LIFE SCIENCES LTD (India), APITORIA PHARMA PRIVATE LTD (India), BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED (India), Dr. Reddy's Laboratories Ltd. (India), GLAND PHARMA LTD (India), Hetero Drugs Limited (India), LIANYUNGANG RUNZHONG PHARMACEUTICAL CO LTD (China) and MAHI DRUGS PRIVATE LIMITED (India), and 9 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Fosaprepitant Dimeglumine Drug Master Files are active?

ALIVUS LIFE SCIENCES LTD (DMF 28992), APITORIA PHARMA PRIVATE LTD (DMF 31470), BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED (DMF 40468), Dr. Reddy's Laboratories Ltd. (DMF 38210, 24829), GLAND PHARMA LTD (DMF 37877), Hetero Drugs Limited (DMF 25614), LIANYUNGANG RUNZHONG PHARMACEUTICAL CO LTD (DMF 28288) and MAHI DRUGS PRIVATE LIMITED (DMF 38731) and 9 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

Does the FDA Orange Book list patents for products containing Fosaprepitant Dimeglumine?

Yes. The latest patent listed for an approved US product containing Fosaprepitant Dimeglumine expires 11 Jan 2039, across 13 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.

How do I qualify a Fosaprepitant Dimeglumine supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Fosaprepitant Dimeglumine?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.